Skip to main content
. 2020 Feb 28;21:135. doi: 10.1186/s12891-020-3126-7

Table 1.

Candidate Selection Criteria for cBMA Treatment

Inclusion Criteria (n = 33)
 • Refractory LBP displaying discogenic degenerative changes via MRI
 • Positive concordant or partial concordant pain on discography and demonstrated internal disc disruption via CT scan (1, 2, or 3-level disc pathology accepted)
 • ≥ 50% disc height maintained at level(s) of treatment
 • No responsiveness to conservative therapy
 • Subjective findings of chronic LBP suggestive of discogenic etiology
 • Patients treated between Apr 2010 – Apr 2015
 • Patients desiring to be treated with concentrated autologous bone marrow aspirate at the level(s) of treatment
Exclusion Criteria
 • LBP caused by any other etiologies (facet pain, stenosis, etc.)
 • < 50% disc height maintained at level(s) of treatment
 • Full-thickness tears
 • Patients who underwent any additional therapies during the follow up period